Biocon's Board has approved issuing ₹570 Cr in commercial papers on a private placement basis. This decision, made on Jan 27, 2025, aligns with SEBI's Listing Obligations (Reg. 30). A strategic move to optimize funding and operations.
#Biocon #investing #StocksInFocus